Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
ANTHIM® (obiltoxaximab) is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs
The report details the trend, potential and market size of Obiltoxaximab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Obiltoxaximabmarket, defines the market attractiveness level of Obiltoxaximab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Obiltoxaximab industry, describes the types of Obiltoxaximab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Obiltoxaximab market and the development prospects and opportunities of Obiltoxaximab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Obiltoxaximab market in Chapter 13.
By Player:
Elusys Therapeutics
By Type:
Adult
Children
By End-User:
Hospital
Drugs Store
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Obiltoxaximab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Obiltoxaximab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Obiltoxaximab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Obiltoxaximab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Obiltoxaximab Market Analysis and Outlook to 2022
-
7.1 Global Obiltoxaximab Consumption (2017-2022)
-
7.2 United States Obiltoxaximab Consumption (2017-2022)
-
7.3 Europe Obiltoxaximab Consumption (2017-2022)
-
7.4 China Obiltoxaximab Consumption (2017-2022)
-
7.5 Japan Obiltoxaximab Consumption (2017-2022)
-
7.6 India Obiltoxaximab Consumption (2017-2022)
-
7.7 South Korea Obiltoxaximab Consumption (2017-2022)
8 Region and Country-wise Obiltoxaximab Market Analysis and Outlook to 2028
-
8.1 Global Obiltoxaximab Consumption Forecast (2022-2028)
-
8.2 United States Obiltoxaximab Consumption Forecast (2022-2028)
-
8.3 Europe Obiltoxaximab Consumption Forecast (2022-2028)
-
8.4 China Obiltoxaximab Consumption Forecast (2022-2028)
-
8.5 Japan Obiltoxaximab Consumption Forecast (2022-2028)
-
8.6 India Obiltoxaximab Consumption Forecast (2022-2028)
-
8.7 South Korea Obiltoxaximab Consumption Forecast (2022-2028)
9 Global Obiltoxaximab Market Outlook by Types and Applications to 2022
-
9.1 Global Obiltoxaximab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Children Consumption and Growth Rate (2017-2022)
-
9.2 Global Obiltoxaximab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Obiltoxaximab Market Outlook by Types and Applications to 2028
-
10.1 Global Obiltoxaximab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Obiltoxaximab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Obiltoxaximab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Obiltoxaximab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Obiltoxaximab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Obiltoxaximab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Obiltoxaximab Market Competitive Analysis
-
14.1 Elusys Therapeutics
-
14.1.1 Elusys Therapeutics Company Details
-
14.1.2 Elusys Therapeutics Obiltoxaximab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Elusys Therapeutics Obiltoxaximab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Obiltoxaximab
-
Figure Obiltoxaximab Picture
-
Table Global Obiltoxaximab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Obiltoxaximab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Obiltoxaximab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Obiltoxaximab Consumption by Country (2017-2022)
-
Figure United States Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Table Europe Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Figure China Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Figure Japan Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Figure India Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Obiltoxaximab Consumption and Growth Rate (2017-2022)
-
Figure Global Obiltoxaximab Consumption Forecast by Country (2022-2028)
-
Figure United States Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Obiltoxaximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Obiltoxaximab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Obiltoxaximab Export by Region (Top 5 Countries) (2017-2028)
-
Table Elusys Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Elusys Therapeutics Obiltoxaximab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elusys Therapeutics Obiltoxaximab Product and Service
-
